Literature DB >> 7873729

Renal cystic disease and ammoniagenesis in Han:SPRD rats.

V E Torres1, D K Mujwid, D M Wilson, K H Holley.   

Abstract

Cyst formation in conditions associated with increased renal ammoniagenesis (hypokalemia, distal renal tubular acidosis, renal mass reduction) and experimental links between increased ammoniagenesis and interstitial inflammation have suggested a role for ammonia in the pathogenesis of polycystic kidney disease (PKD). To explore this hypothesis, Han:SPRD rats, a PKD model that affects male more severely than female animals, have been used. Heterozygous cystic (Cy/+) and homozygous normal (+/+) male and female offspring of Cy/+ rats were divided at 3 wk of age into control groups drinking water and experimental groups drinking 300 mM NH4Cl, 300 mM KHCO3, 200 mM KHCO3, 200 mM KCl, 200 mM NaHCO3, or 200 mM NaCl. At 2 months of age, the rats were kept fasting from 8:00 p.m. to 8:00 a.m. in metabolic cages and urine samples were collected under mineral oil. The rats were then weighed and anesthetized for the collection of blood and kidneys. The administration of 300 mM NH4Cl, and to a lesser extent that of 200 mM NaCl, was accompanied by an increase in the urinary excretion of ammonia and aggravation of the renal cystic disease. On the other hand, the administration of 300 mM KHCO3, 200 mM KHCO3, or 200 mM NaHCO3 lowered the urinary excretion of ammonia and markedly reduced the severity of the cystic disease and interstitial inflammation. The administration of 300 mM KHCO3, and to a lesser extent that of 200 mM KHCO3, resulted in the precipitation of calcium phosphate in the medullary collecting ducts.(ABSTRACT TRUNCATED AT 250 WORDS)

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 7873729     DOI: 10.1681/ASN.V551193

Source DB:  PubMed          Journal:  J Am Soc Nephrol        ISSN: 1046-6673            Impact factor:   10.121


  11 in total

1.  Renal cysts and nephrocalcinosis in a patient with Bartter syndrome type III.

Authors:  Toru Watanabe; Toshihiro Tajima
Journal:  Pediatr Nephrol       Date:  2005-02-17       Impact factor: 3.714

2.  NH4Cl Treatment Prevents Tissue Calcification in Klotho Deficiency.

Authors:  Christina B Leibrock; Ioana Alesutan; Jakob Voelkl; Tatsiana Pakladok; Diana Michael; Erwin Schleicher; Zahra Kamyabi-Moghaddam; Leticia Quintanilla-Martinez; Makoto Kuro-o; Florian Lang
Journal:  J Am Soc Nephrol       Date:  2015-02-02       Impact factor: 10.121

3.  Luminal alkalinization attenuates proteinuria-induced oxidative damage in proximal tubular cells.

Authors:  Tomokazu Souma; Michiaki Abe; Takashi Moriguchi; Jun Takai; Noriko Yanagisawa-Miyazawa; Eisuke Shibata; Yasutoshi Akiyama; Takafumi Toyohara; Takehiro Suzuki; Masayuki Tanemoto; Takaaki Abe; Hiroshi Sato; Masayuki Yamamoto; Sadayoshi Ito
Journal:  J Am Soc Nephrol       Date:  2011-03-03       Impact factor: 10.121

Review 4.  Short- and long-term effects of alkali therapy in chronic kidney disease: a systematic review.

Authors:  Paweena Susantitaphong; Kamal Sewaralthahab; Ethan M Balk; Bertrand L Jaber; Nicolaos E Madias
Journal:  Am J Nephrol       Date:  2012-05-29       Impact factor: 3.754

Review 5.  Recent advances in understanding the pathogenesis of polycystic kidney disease: therapeutic implications.

Authors:  Benjamin D Cowley
Journal:  Drugs       Date:  2004       Impact factor: 9.546

6.  Modulation of renal injury in pcy mice by dietary fat containing n-3 fatty acids depends on the level and type of fat.

Authors:  Deepa Sankaran; Jing Lu; Neda Bankovic-Calic; Malcolm R Ogborn; Harold M Aukema
Journal:  Lipids       Date:  2004-03       Impact factor: 1.880

7.  Acetazolamide sensitive tissue calcification and aging of klotho-hypomorphic mice.

Authors:  Christina B Leibrock; Ioana Alesutan; Jakob Voelkl; Diana Michael; Tatsiana Castor; Ursula Kohlhofer; Leticia Quintanilla-Martinez; Laura Kübler; Julia G Mannheim; Bernd J Pichler; Kevin P Rosenblatt; Makoto Kuro-o; Florian Lang
Journal:  J Mol Med (Berl)       Date:  2015-08-27       Impact factor: 4.599

Review 8.  Therapeutic Interference With Vascular Calcification-Lessons From Klotho-Hypomorphic Mice and Beyond.

Authors:  Florian Lang; Christina Leibrock; Lisann Pelzl; Meinrad Gawaz; Burkert Pieske; Ioana Alesutan; Jakob Voelkl
Journal:  Front Endocrinol (Lausanne)       Date:  2018-05-04       Impact factor: 5.555

9.  Role of Bicaudal C1 in renal gluconeogenesis and its novel interaction with the CTLH complex.

Authors:  Lucia Carolina Leal-Esteban; Benjamin Rothé; Simon Fortier; Manuela Isenschmid; Daniel B Constam
Journal:  PLoS Genet       Date:  2018-07-11       Impact factor: 5.917

10.  The intermediate-conductance calcium-activated potassium channel KCa3.1 contributes to alkalinization-induced vascular calcification in vitro.

Authors:  Yaling Bai; Jinsheng Xu; Shuo Yang; Huiran Zhang; Lei He; Wei Zhou; Meijuan Cheng; Shenglei Zhang
Journal:  J Clin Lab Anal       Date:  2021-07-27       Impact factor: 2.352

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.